Signature substrate mutations associated with HIV-1 protease inhibitor resistance

被引：0
|
作者：
Kolli, M. [1 ]
Stawiski, E. [2 ]
Chappey, C. [2 ]
Parkin, N. [2 ]
Schiffer, C. A. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
[2] Monogram Biosci Inc, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [21] HIV-1 protease inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [22] Combining mutations in HIV-1 protease to understand mechanisms of resistance
    Mahalingam, B
    Boross, P
    Wang, YF
    Louis, JM
    Fischer, CC
    Tozser, J
    Harrison, RW
    Weber, IT
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 48 (01) : 107 - 116
  • [23] HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance
    Kolli, Madhavi
    Ozen, Aysegul
    Kurt-Yilmaz, Nese
    Schiffer, Celia A.
    JOURNAL OF VIROLOGY, 2014, 88 (13) : 7145 - 7154
  • [24] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Marcelin, A. G.
    Lambert-Niclot, S.
    Canestri, A.
    Soulie, C.
    Wirden, M.
    Tubiana, R.
    Cheret, A.
    Katlama, C.
    Flandre, P.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A51 - A51
  • [25] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Malet, Isabelle
    Canestri, Ana
    Soulie, Cathia
    Tubiana, Roland
    Brunet, Christel
    Wirden, Marc
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 905 - 908
  • [26] HIV-1 envelope facilitates the development of protease inhibitor resistance through acquiring mutations associated with viral entry and immune escape
    Maphumulo, Ntombikhona F.
    Gordon, Michele L.
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [27] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance
    Lataillade, M.
    Chiarella, J.
    Kozal, M. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S28 - S28
  • [28] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance
    Lataillade, Max
    Chiarella, Jennifer
    Kozal, Michael J.
    ANTIVIRAL THERAPY, 2007, 12 (04) : 563 - 570
  • [29] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [30] The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients
    Karmochkine, M
    Mohamed, AS
    Piketty, C
    Ginsburg, C
    Raguin, G
    Schneider-Fauveau, V
    Gutmann, L
    Kazatchkine, MD
    Belec, L
    ANTIVIRAL RESEARCH, 2000, 47 (03) : 179 - 188
12345